A randomized, controlled trial of interferon alfa-2b alone and with simultaneous prednisone for the treatment of chronic hepatitis B

This publication has 14 references indexed in Scilit:

• A controlled trial of interferon with or without prednisone priming for chronic hepatitis B
  Gastroenterology, 1992
• Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study
  Journal of Hepatology, 1990
• Randomized controlled trial of adenine arabinoside 5′-monophosphate in chronic active hepatitis B: Comparison of the efficacy in heterosexual and homosexual patients
  Hepatology, 1989
• Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.
  Gut, 1989
• Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B
  Gastroenterology, 1988
• Prednisone Withdrawal Followed by Recombinant Alpha Interferon in the Treatment of Chronic Type B Hepatitis
  Annals of Internal Medicine, 1988
• Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B
  Gastroenterology, 1985
• Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.
  Gut, 1985
• Comparative efficacy of adenine arabinoside 5′ monophosphate and prednisone withdrawal followed by adenine arabinoside 5′ monophosphate in the treatment of chronic active hepatitis type B
  Gastroenterology, 1985
• Survival in Chronic Hepatitis B
  Annals of Internal Medicine, 1984